Gene-environment interrelations in prostate cancer

Epidemiologic Reviews

Volumn 23, Issue 1, 2001, Pages 163-167

  Hayes, Richard B ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Bethesda   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HEREDITY; HIGH RISK POPULATION; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

EID: 0034801502     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a000784     Document Type: Review

References (44)

1. Evidence of an X-linked or recessive genetic component to prostate cancer risk
2. Mendelian inheritance of familial prostate cancer
3. Evidence for autosomal dominant inheritance of prostate cancer
4. Environmental and heritable factors in the causation of cancer
5. Innovative study designs and analytic approaches to the genetic epidemiology of cancer
6. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search
7. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43
8. Analysis of chromosome 1q42.2-43 in 152 families with high risk of prostate cancer
9. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36
10. In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancer
11. Evidence for a prostate cancer susceptibility locus on the X chromosome
12. Evidence for a prostate cancer-susceptibility locus on chromosome 20
13. No evidence of linkage for chromosome 1q42.2-43 in prostate cancer
14. Combined analysis of hereditary prostate cancer linkage to 1q24-25: Results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics
15. A candidate prostate cancer susceptibility gene at chromosome 179
16. Association of HPC2/ELAC2 genotypes and prostate cancer
17. Oral contraceptives and the risk of hereditary ovarian cancer
18. N-acetyltransferase phenotype and risk in urinary bladder cancer: Approaches in molecular epidemiology. Preliminary results in Sweden and Denmark
19. Role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmacogenetic epidemiologic approach to bladder cancer
20. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat prostate and induction of invasive carcinomas by subsequent treatment with testosterone propionate
21. Metabolic activation of carcinogens and expression of various cytochrome P450 in human prostate tissue
22. N-acetyltransferase 1 genetic polymorphism influences the risk of prostate cancer development
23. Debrisoquine hydroxylase (CYP2D6) and prostate cancer
24. Glutathione S-transferase-mu (GSTM1) and -theta (GSTT1) genotypes in the etiology of prostate cancer
25. 609 C→T polymorphism in NAD(P)H: Quinone oxidoreductase gene in patients with prostatic adenocarcinoma or benign prostatic hyperplasia
26. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer
27. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor
28. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
29. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer
30. Polymorphic repeats in the androgen receptor gene: Molecular markers of prostate cancer risk
31. (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population
32. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk
33. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: A population-based case-control study in China
34. Susceptibility to prostate cancer: Interaction between genotypes at the androgen receptor and prostate-specific antigen loci
35. On power and sample-size for studying features of the relative odds of disease
36. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: A case-series meta-analysis of a gene-environment interaction
37. Gene mapping in the 20th and 21 st centuries: Statistical methods, data analysis, and experimental design
38. The future of genetic studies of complex human diseases
39. Guilt by association
40. Use of unlinked genetic markers to detect population stratification in association studies
41. Population stratification in epidemiologic studies of common genetic variants and cancer: Quantification of bias
42. Choosing a retrospective design to assess joint genetic and environmental contributions to risk
43. Searching for genetic determinants in the new millennium